Menu Back to Committee

Programme Committee

Meet the EuroMeeting Co-chairs

Karl Broich 

Karl Broich
President
BfArM, Germany

      

Malik Kemal

Kemal Malik
Member of the Board of Management
Bayer AG, Germany

A Message from the Co-chairs

Program Committee

  • Karl  Broich, DrMed
    Karl Broich, DrMed President
    Federal Institute for Drugs and Medical Devices (BfArM), Germany
  • Kemal Z. Malik
    Kemal Z. Malik Member of the Board of Management
    Bayer, Germany
  • Peter  Arlett, MD, FFPM, FRCP
    Peter Arlett, MD, FFPM, FRCP Head Data Analytics and Methods Task Force, EMA
    European Medicines Agency, Netherlands
  • Peter  Bachmann
    Peter Bachmann Deputy-Head, European Union and International Affairs
    Federal Institute for Drugs and Medical Devices (BfArM), Germany
  • Francesca  Cerreta, PharmD, MPharm, MS
    Francesca Cerreta, PharmD, MPharm, MS Principal Scientific Officer
    European Medicines Agency, Netherlands
  • Michael  Devoy
    Michael Devoy
    Bayer AG Pharma AG, Germany
  • Petra  Doerr, PharmD, RPh
    Petra Doerr, PharmD, RPh Director/Owner
    Petra Dörr Consulting GmbH/Ltd., Switzerland
  • Emma  Du Four, MBA
    Emma Du Four, MBA Head of International Regulatory Policy
    Abbvie, United Kingdom
  • Hans-Georg  Eichler, MD, MSc
    Hans-Georg Eichler, MD, MSc Senior Medical Officer
    European Medicines Agency, Netherlands
  • Edith  Frenoy, MA, MSc
    Edith Frenoy, MA, MSc Director Market Access, HTA policy lead
    EFPIA, Belgium
  • Matthias  Gottwald
    Matthias Gottwald Head R&D Policy and Networking
    Bayer Pharma AG, Germany
  • Martin  Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM Governance and Board Relations Manager, External Relations Team
    Unitaid, Netherlands
  • Niklas  Hedberg, MPharm
    Niklas Hedberg, MPharm Chair EUnetHTA Executive Board, Chief Pharmacist
    Dental and Pharmaceutical Benefits Agency, TLV, Sweden
  • Sabina  Hoekstra-van den Bosch, PharmD, MSc, RPh
    Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh Regulatory Strategy Principal
    Tüv Süd, Netherlands
  • Alastair  Kent, MHS
    Alastair Kent, MHS Director
    Genetic Alliance UK, United Kingdom
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc EU QPPV Deputy
    Merck Sharp + Dohme B.V., Netherlands
  • Birka  Lehmann, MD
    Birka Lehmann, MD Senior Expert Drug Regulatory Affairs
    Germany
  • Monika  Lessl
    Monika Lessl Head of Innovation Strategy
    Bayer AG, Germany
  • Sabine  Luik
    Sabine Luik EFPIA Member ICH Steering Committee, Sr Vice President Medicine & Regulatory
    Boehringer Ingelheim Pharmaceuticals, United States
  • Detlef  Nehrdich, MSc
    Detlef Nehrdich, MSc Senior Associate
    Waife & Associates, Germany
  • Luca  Pani, MD
    Luca Pani, MD Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences
    University of Miami, United States
  • Kristin  Raudsepp, MD
    Kristin Raudsepp, MD Director General
    State Agency of Medicines, Estonia
  • Holger Maria  Rohde, PhD, MBA, MSc
    Holger Maria Rohde, PhD, MBA, MSc Director Regulatory Project Management
    Merck KGaA, Germany
  • Thomas M. Schindler, PhD
    Thomas M. Schindler, PhD Head Medical Writing Europe
    Boehringer Ingelheim Pharma GmbH & Co.KG, Germany
  • Isabelle  Stoeckert, PharmD
    Isabelle Stoeckert, PharmD
    Bayer, Germany
  • Florian  von Raison, DrMed
    Florian von Raison, DrMed Senior Global Program Head and Chairman Geriatric Medicine Working Party/ EFGCP
    Novartis Pharma AG, Switzerland
  • Margaret Anne Walters
    Margaret Anne Walters Deputy EU Qualified Person for Pharmacovigilance
    Merck, Sharp & Dohme Ltd, United Kingdom
  • John  Wilkinson
    John Wilkinson Director of Devices
    MHRA, United Kingdom
  • Milan  Zdravkovic, MD
    Milan Zdravkovic, MD Senior Vice President, Head of Research & Development
    Swedish Orphan Biovitrum AB, Sweden
Load More